Revance Therapeutics shares owned by Bellevue Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Bellevue Asset Management
from 13F filings
Historical chart of Bellevue Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Bellevue Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.2k | 138 | 8.79 |
2023-09-30 | $1.1k | 93 | 11.46 |
2023-06-30 | $2.4k | 93 | 25.30 |
2023-03-31 | $3.0k | 93 | 32.20 |
2022-12-31 | $1.4k | 76 | 18.20 |
2022-09-30 | $2.0k | 76 | 26.32 |
2022-06-30 | $1.0k | 76 | 13.16 |
2022-03-31 | $1.0k | 76 | 13.16 |
2021-12-31 | $2.0k | 92 | 21.74 |
2021-09-30 | $3.0k | 99 | 30.30 |
2021-06-30 | $3.0k | 99 | 30.30 |
2021-03-31 | $3.0k | 108 | 27.78 |
2020-12-31 | $3.0k | 123 | 24.39 |
2020-09-30 | $2.0k | 67 | 29.85 |
2020-06-30 | $2.0k | 67 | 29.85 |
2020-03-31 | $1.0k | 67 | 14.93 |
2019-12-31 | $999 | 33 | 30.30 |